ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2008
Biomarkers for cancer cachexia: is there also a genetic component to cachexia?
Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review.Journal of genetics · 2011Pooled it
- Identification of cachexia in lung cancer patients with an ensemble learning approach.Frontiers in nutrition · 2024Article
- Association of the rs3917647 polymorphism of the SELP gene with malnutrition in gastric cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Article
- TNF-α-1031T/C gene polymorphism as a predictor of malnutrition in patients with gastric cancer.Frontiers in nutrition · 2023Article
- Evidence for reciprocal network interactions between injured hearts and cancer.Frontiers in cardiovascular medicine · 2022Review
- Palliative and end-of-life care research in Scotland 2006-2015: a systematic scoping review.BMC palliative care · 2018Article
- Protein calorie malnutrition, nutritional intervention and personalized cancer care.Oncotarget · 2017Review
- Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6.SpringerPlus · 2016Review
- The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia.Medical oncology (Northwood, London, England) · 2015Article
- Prevalence and Predictors of Malnutrition in Nasopharyngeal Carcinoma.Clinical medicine insights. Ear, nose and throat · 2015Article
- Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia.Mediators of inflammation · 2015Review
- C-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients.Molecular diagnosis & therapy · 2012Article
- Is there a genetic cause for cancer cachexia? - a clinical validation study in 1797 patients.British journal of cancer · 2011Article
- The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2010Article
- Treatment of cachexia in oncology.Indian journal of palliative care · 2010Article
- Interleukin-10 gene polymorphisms influence susceptibility to cachexia in patients with low-third gastric cancer in a Chinese population.Molecular diagnosis & therapy · 2010Article
- More is better: a multimodality approach to cancer cachexia.The oncologist · 2010Article
- Cancer cachexia: medical management.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2010Review
- Association of interleukin-8 with cachexia from patients with low-third gastric cancer.Comparative and functional genomics · 2009Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCancer cachexia is a severe debilitating disorder, which causes significant morbidity and mortality. In clinical practice, cachexia is often not treated until a late stage, when therapeutic options are limited.
objectiveIt is therefore of great interest to analyse early biomarkers of this syndrome.
conclusionIn this review article, we summarise recent biomarkers found in various body compartments. We also explore the likelihood of a genetic predisposition to cachexia and focus on the potential role of single nucleotide polymorphisms in genes coding for pro- and anti-inflammatory cytokines, and 'atrogenes' associated with wasting in skeletal muscle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.